The Role of Radiotherapy in the Management of Vaginal Melanoma: A Literature Review with a Focus on the Potential Synergistic Role of Immunotherapy

被引:4
作者
Cuccia, Francesco [1 ]
D'Alessandro, Salvatore [1 ,2 ]
Blasi, Livio [3 ]
Chiantera, Vito [4 ]
Ferrera, Giuseppe [1 ]
机构
[1] ARNAS Civ Hosp, Radiotherapy Unit, Radiat Oncol, I-90100 Palermo, Italy
[2] Univ Palermo, Radiat Oncol Sch, I-90100 Palermo, Italy
[3] ARNAS Civ Hosp, Med Oncol, I-90100 Palermo, Italy
[4] ARNAS Civ Hosp, Gynecol Oncol, I-90100 Palermo, Italy
来源
JOURNAL OF PERSONALIZED MEDICINE | 2023年 / 13卷 / 07期
关键词
vaginal melanoma; radiotherapy; immunotherapy; PRIMARY MALIGNANT-MELANOMA; CARBON ION RADIOTHERAPY; RADIATION; THERAPY;
D O I
10.3390/jpm13071142
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Among the mucosal melanomas, vaginal melanomas are very rare tumors, accounting for less than 20% of melanomas arising from the female genital tract. They occur most frequently in women in post-menopausal age, but younger patients may also experience this neoplasm, mainly located in the lower third of the vagina or the anterior wall. The optimal management of this tumor remains controversial, with surgery reported as the most frequently adopted approach. However, a clear benefit of surgical treatment in terms of survival has not yet been demonstrated. Conversely, radiotherapy may represent an attractive non-invasive alternative, and there are several favorable reports of the role of radiation therapy, either delivered with photons, brachytherapy, or hadrontherapy. A wide range of techniques and fractionation regimens are reported with substantially good tolerance to the treatment, and acute G3 or higher toxicities are reported only in the case of concurrent immunotherapy. Of note, due to the rarity of the disease, there is a lack of high-level evidence for the optimal therapeutic option. In this scenario, recent studies theorize the possibility of developing combinatorial approaches of radiotherapy with immunotherapy based on cutaneous melanomas reports. In this review, we aim to summarize the evidence available in the literature supporting the role of definitive radiotherapy for vaginal melanomas, with a focus on the combination of RT with immunotherapy, in terms of optimal timing and biological rationale.
引用
收藏
页数:9
相关论文
共 42 条
  • [1] Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; efficacy and safety of combined treatment
    Anderson, Erik S.
    Postow, Michael A.
    Wolchok, Jedd D.
    Young, Robert J.
    Ballangrud, Ase
    Chan, Timothy A.
    Yamada, Yoshiya
    Beal, Kathryn
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [2] Re-irradiation With Carbon Ion Radiotherapy for Pelvic Rectal Cancer Recurrences in Patients Previously Irradiated to the Pelvis
    Barcellini, Amelia
    Vitolo, Viviana
    Cobianchi, Lorenzo
    Peloso, Andrea
    Vanoli, Alessandro
    Mirandola, Alfredo
    Facoetti, Angelica
    Fiore, Maria Rosaria
    Iannalfi, Alberto
    Vischioni, Barbara
    Cuccia, Francesco
    Ronchi, Sara
    Bonora, Maria
    Riva, Giulia
    Petrucci, Rachele
    D'Ippolito, Emma
    Dal Mas, Francesca
    Preda, Lorenzo
    Valvo, Francesca
    [J]. IN VIVO, 2020, 34 (03): : 1547 - 1553
  • [3] Feasibility of Carbon Ion Radiotherapy in the Treatment of Gynecological Melanoma
    Barcellini, Amelia
    Vitolo, Viviana
    Facoetti, Angelica
    Fossati, Piero
    Preda, Lorenzo
    Fiore, Maria Rosaria
    Vischioni, Barbara
    Iannalfi, Alberto
    Bonora, Maria
    Ronchi, Sara
    D'Ippolito, Emma
    Petrucci, Rachele
    Viselner, Gisela
    Ciocca, Mario
    Valvo, Francesca
    Orecchia, Roberto
    [J]. IN VIVO, 2019, 33 (02): : 473 - 476
  • [4] Radiation, Immune Checkpoint Blockade and the Abscopal Effect: A Critical Review on Timing, Dose and Fractionation
    Buchwald, Zachary S.
    Wynne, Jacob
    Nasti, Tahseen H.
    Zhu, Simeng
    Mourad, Waleed
    Yan, Weisi
    Gupta, Seema
    Khleif, Samir N.
    Khan, Mohammad K.
    [J]. FRONTIERS IN ONCOLOGY, 2018, 8
  • [5] SBRT for elderly oligometastatic patients as a feasible, safe and effective treatment opportunity
    Cuccia, Francesco
    Mazzola, Rosario
    Pastorello, Edoardo
    Figlia, Vanessa
    Giaj-Levra, Niccolo
    Nicosia, Luca
    Ricchetti, Francesco
    Rigo, Michele
    Attina, Giorgio
    Vitale, Claudio
    Ruggieri, Ruggero
    Alongi, Filippo
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 2021, 38 (05) : 475 - 481
  • [6] Outcome and Toxicity of Carbon Ion Radiotherapy for Axial Bone and Soft Tissue Sarcomas
    Cuccia, Francesco
    Fiore, Maria Rosaria
    Barcellini, Amelia
    Iannalfi, Alberto
    Vischioni, Barbara
    Ronchi, Sara
    Bonora, Maria
    Riva, Giulia
    Vai, Alessandro
    Facoetti, Angelica
    Preda, Lorenzo
    Valvo, Francesca
    Vitolo, Viviana
    [J]. ANTICANCER RESEARCH, 2020, 40 (05) : 2853 - 2859
  • [7] Combining radiation plus immunotherapy to improve systemic immune response
    Cushman, Taylor R.
    Gomez, Daniel
    Kumar, Rachit
    Likacheva, Anna
    Chang, Joe Y.
    Cadena, Alex P.
    Paris, Sebastien
    Welsh, James W.
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 : S468 - S479
  • [8] Stereotactic radiosurgery and ipilimumab for patients with melanoma brain metastases: clinical outcomes and toxicity
    Diao, Kevin
    Bian, Shelly X.
    Routman, David M.
    Yu, Cheng
    Ye, Jason C.
    Wagle, Naveed A.
    Wong, Michael K.
    Zada, Gabriel
    Chang, Eric L.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2018, 139 (02) : 421 - 429
  • [9] A Novel Radiotherapeutic Approach to Treat Bulky Metastases Even From Cutaneous Squamous Cell Carcinoma: Its Rationale and a Look at the Reliability of the Linear-Quadratic Model to Explain Its Radiobiological Effects
    Ferini, Gianluca
    Castorina, Paolo
    Valenti, Vito
    Illari, Salvatore Ivan
    Sachpazidis, Ilias
    Castorina, Luigi
    Marrale, Maurizio
    Pergolizzi, Stefano
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [10] Use of extracranial radiation therapy in metastatic melanoma patients receiving immunotherapy
    Gabani, Prashant
    Robinson, Clifford G.
    Ansstas, George
    Johanns, Tanner M.
    Huang, Jiayi
    [J]. RADIOTHERAPY AND ONCOLOGY, 2018, 127 (02) : 310 - 317